SCHEMBL9112157

SCHEMBL9112157

[CH]=CC=CCCC1CCCCN1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
LMNA P02545 2/20 0.41
TP53 P04637 2/20 0.41
CYP1A2 P05177 2/20 0.41
HTR1A P08908 2/20 0.41
HTR2A P28223 2/20 0.41
KCNH2 Q12809 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
MLNR O43193 1/20 0.41
ABCB11 O95342 1/20 0.41
EGFR P00533 1/20 0.41
FYN P06241 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9109449 0.76 CYP2D6 (0.42) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL9114620 0.76 CYP2D6 (0.32) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL7349463 0.73 KMT2A (0.46) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL21556543 0.73 CYP2D6 (0.46) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL9111943 0.72 KMT2A (0.36) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL5062322 0.72 CYP2D6 (0.44) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL6413011 0.70 KMT2A (0.41) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL5932936 0.69 CYP2D6 (0.44) CYP2D6KMT2AMEN1LMNATP53
Hydrochloric Acid SCHEMBL29753604 0.68 KMT2A (0.41) CYP2D6KMT2AMEN1LMNATP53
SCHEMBL7122129 0.68 CYP2D6 (0.41) CYP2D6KMT2AMEN1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed